EUCTR2007-005056-16-IT进行中（未招募）1 期
Atorvastatin at high dosage before coronary stent surgery: effect on peri-procedure miocardic stroke . - ND
OSPEDALE S. RAFFAELE0 个研究点目标入组 700 人开始时间: 2007年11月21日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 700
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1)age > or equal 18 yeras old; 2) no ongoing treatment with statine 3)new stenosis on native vassel
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1) pregnancy; 2) acute pulmonary edema ;3)acute miocardic stroke and/or acute coronaric syndrome; 4) high values of cardiac enzymes; 5) recent (2 days or more) acute miocardic stroke and/or acute coronaric syndrome; 6) patients enrolled in omgoing studies; 7) ongoing statine system; 8) chronic renal insufficiency in dialisis; 9) intollerance history to statine, ticopidina or clopidogrel; 10) ongoing treatment withglicoproteina IIbIIIa inhibitors;
研究者
相似试验
已完成
4 期
Statin Recapture Therapy before Coronary Artery Bypass Grafting.I25.1Atherosclerotic heart diseaseDRKS00000753niversitätsklinikum Köln2,630
进行中（未招募）
不适用
Statins IN TREATMENT OF ACUTE coronary syndrome. COMPARISON OF EFFICACY BETWEEN Atorvastatin and Rosuvastatin IN PATIENTS UNDERGO A PTCA THROUGH THE MONITORING OF C REACTIVE PROTEIN - NDPatients with Acute coronary syndrome without up-leveling of ST line.MedDRA version: 9.1Level: SOCClassification code 10007541MedDRA version: 9.1Level: HLTClassification code 10011085EUCTR2009-012850-19-ITAZIENDA SANITARIA LOCALE DI BARI
已完成
不适用
High dose atorvastatin effects on cardiac biomarkers (24 hours after CABG)IRCT2016112231024N1Tehran University of Medical Sciences118
尚未招募
4 期
A clinical trial to compare the preventive effects of Atorvastatin and Rosuvasatin on kidney damage in patients undergoing cardiac surgeryCTRI/2023/08/056801Sreeja Nittoori
进行中（未招募）
1 期
TRial of Atorvastatin for the primary prevention of Cardiovascular Events in Rheumatoid Arthritis - TRACE RARheumatoid arthritis is associated with increased mortality from cardiovascular disease (CVD). Statins have a proven effect in reducing CVD events in at-risk populations, mostly due to their cholesterol-lowering properties, but possibly through anti-inflammatory and immunomodulatory effects. This trial will assess the hypothesis that atorvastatin is more effective than placebo in the primary prevention of cardiovascular events in patients with RA.EUCTR2006-006032-22-GBniversity of Manchester5,350